Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |